Aastrom Biosciences to Present at RBC Capital Markets Healthcare Conference Ann Arbor, Michigan, December 7, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM), a clinical development stage company focused on the use of autologous cells for regenerative medicine, today announced that George W.

Aastrom Biosciences to Present at BMO Capital Markets Healthcare Conference Ann Arbor, Michigan, November 30, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) ), a clinical development stage company focused on the use of autologous cells for regenerative medicine, today announced that George W.

Stephen G. Sudovar Elected Chairman of Aastrom Biosciences' Board of Directors Ann Arbor, Michigan, November 16, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM), a clinical development stage company focused on the use of autologous cells for regenerative medicine, announced today that Stephen G.

Company Reports Clinical Progress and Strengthened Management Team

Webcast Alert: Aastrom Biosciences Announces Its First Quarter Investor Conference Call Ann Arbor, MI, November 3, 2006 -- Aastrom Biosciences, Inc. (NASDAQ: ASTM) announces the following Webcast: What: Aastrom Biosciences, Inc. First Quarter Fiscal Year 2007 Investor Conference Call When:

Aastrom Biosciences to Present at Rodman & Renshaw Ann Arbor, Michigan, November 2, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that George W. Dunbar, President and Chief Executive Officer, and Elmar R. Burchardt, MD, PhD, Vice President, Medical Affairs, will present at the

Webcast Alert: Aastrom Biosciences Announces Webcast of Its Annual Meeting of Shareholders Ann Arbor, MI, October 27, 2006 -- Aastrom Biosciences (NASDAQ: ASTM) announces the following Webcast: What: Aastrom Biosciences Fiscal Year 2006 Annual Meeting of Shareholders When: Thursday, November 2,

Ronnda L. Bartel, Ph.D. Joins Aastrom Biosciences As Vice President Research & Development Ann Arbor, Michigan, October 16, 2006 – Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that Ronnda L. Bartel, Ph.D. has joined the Company as Vice President of Research and Development. Dr.

Aastrom Biosciences to Present at BIO Investor Forum Ann Arbor, Michigan, October 12, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that George W. Dunbar, President and Chief Executive Officer, will be presenting at the 2006 BIO Investor Forum.

Aastrom Biosciences' CFO to Present at Noble Financial Group Small Cap Conference Ann Arbor, Michigan, September 21, 2006 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that Gerald D. Brennan, Jr., Vice President Administrative & Financial Operations and Chief Financial Officer, will